Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C

被引:2
作者
Assmar, Mehdi [1 ]
Yeganeh, Sara [1 ]
Mansourghanaei, Fariborz [2 ]
Amirmozafari, Nour [3 ]
机构
[1] Islamic Azad Univ, Dept Microbiol, Lahijan, Iran
[2] Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran
[3] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran
关键词
Tumor markers; Hepatitis B; Hepatitis C; ELISA; CLINICAL-IMPLICATIONS; ALPHA-FETOPROTEIN; LIVER-DISEASE; SERUM; CANCER; EPIDEMIOLOGY; PREVALENCE; INFECTION; ANTIGEN;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: This study aimed to determine the role of tumor markers AFP, CA15-3, CA125, CA19-9 and CEA in patients with hepatitis B and C. Methods: This descriptive cross-sectional study was performed from Oct 2012 to Oct 2014. Serum samples of 129 patients with hepatitis B and C referred to Guilan Liver and Digestive Disease Research Center in Rasht, Iran were collected and checked for the existence of the listed tumor markers by ELISA. Results: No increase in serum levels of tumor marker CA19-9, CEA and CA15-3 were seen in patients with hepatitis (P>0.05). In patients with hepatitis B, increase in CA125 were observed (P=0.03). In hepatitis C patients, there was an increase in AFP levels (P=0.03). Conclusion: The levels of AFP and CA125 markers were high in hepatitis C and hepatitis B, respectively. However, the increased levels were not seen is malignancy. Due to the small sample size, further study is necessary to find the reasons of the increase.
引用
收藏
页码:1645 / 1651
页数:7
相关论文
共 50 条
  • [31] Expression and Significance of ER, PR, VEGF, CA15-3, CA125 and CEA in Judging the Prognosis of Breast Cancer
    Zhang, Su-Jie
    Hu, Yi
    Qian, Hai-Li
    Jiao, Shun-Chang
    Liu, Zhe-Feng
    Tao, Hai-Tao
    Han, Lu
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3937 - 3940
  • [32] Diagnostic values of serum tumor markers CA72-4, SCCAg, CYFRA21-1, NSE, AFU, CA125, CA19-9, CEA and FER in nasopharyngeal
    Tang, Yong-Fei
    Li, Wen
    Yuan, Jing-Ping
    Huang, Ya-Bing
    Yan, Hong-Lin
    Liu, Lin
    Li, Xiang-Pan
    Wang, Ming
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (06) : 1406 - 1412
  • [33] DISTRIBUTION OF CARCINOMA ANTIGENS CA19-9 AND CA15-3 - AN IMMUNOHISTOCHEMICAL STUDY OF 400 TUMORS
    GATALICA, Z
    MIETTINEN, M
    APPLIED IMMUNOHISTOCHEMISTRY, 1994, 2 (03): : 205 - 211
  • [34] Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer
    Luo, Hai
    Shen, Kexin
    Li, Bo
    Li, Ruiqi
    Wang, Zeming
    Xie, Zhongshi
    ONCOLOGY LETTERS, 2020, 20 (01) : 742 - 750
  • [35] Intralobar pulmonary sequestration presenting increased serum CA19-9 and CA125
    Yagyu, H
    Adachi, H
    Furukawa, K
    Nakamura, H
    Sudoh, A
    Oh, S
    Tsuchida, F
    Kishi, K
    Saitou, M
    Matsuoka, T
    INTERNAL MEDICINE, 2002, 41 (10) : 875 - 878
  • [36] Maternal serum CA125 and CA15-3 antigen levels in normal and pathological pregnancy
    Bon, GG
    Kenemans, P
    Verstraeten, AA
    Go, S
    Philipi, PA
    van Kamp, GJ
    van Geijn, HP
    van Vugt, JMG
    FETAL DIAGNOSIS AND THERAPY, 2001, 16 (03) : 166 - 172
  • [37] Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?
    Nikolaos Thomakos
    Alexandros Rodolakis
    Flora Zagouri
    Dimitrios Zacharakis
    Maria Sotiropoulou
    Nikolaos Akrivos
    Dimitrios Haidopoulos
    Christos A. Papadimitriou
    Meletios-Athanassios Dimopoulos
    Aris Antsaklis
    Archives of Gynecology and Obstetrics, 2013, 287 : 97 - 102
  • [38] Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?
    Thomakos, Nikolaos
    Rodolakis, Alexandros
    Zagouri, Flora
    Zacharakis, Dimitrios
    Sotiropoulou, Maria
    Akrivos, Nikolaos
    Haidopoulos, Dimitrios
    Papadimitriou, Christos A.
    Dimopoulos, Meletios-Athanassios
    Antsaklis, Aris
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 287 (01) : 97 - 102
  • [39] THE PROGNOSTIC VALUE OF CEA, BETA-HCG, AFP, CA125, CA19-9 AND C-ERB B-2, BETA-HCG IMMUNOHISTOCHEMISTRY IN ADVANCED COLORECTAL-CANCER
    WEBB, A
    SCOTTMACKIE, P
    CUNNINGHAM, D
    NORMAN, A
    ANDREYEV, J
    OBRIEN, M
    BENSTED, J
    ANNALS OF ONCOLOGY, 1995, 6 (06) : 581 - 587
  • [40] Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinoma
    Xu, Hua-Xiang
    Li, Shuo
    Wu, Chun-Tao
    Qi, Zi-Hao
    Wang, Wen-Quan
    Jin, Wei
    Gao, He-Li
    Zhang, Shi-Rong
    Xu, Jin-Zhi
    Liu, Chen
    Long, Jiang
    Xu, Jin
    Ni, Quan-Xing
    Yu, Xian-Jun
    Liu, Liang
    PANCREATOLOGY, 2018, 18 (06) : 671 - 677